Neothetics, Inc. (NEOT)

[b__g]

Merger brings NEOT a billion dollar contraceptive in phase III trials which may make the use of a condoms nearly obsolete.
Prevents conception and certain sexually transmitted diseases.

Amphora® is an on-demand non-hormonal, woman controlled, surfactant-free investigational new drug being developed as a vaginal contraceptive and for the prevention of certain sexually transmitted infections. Amphora® is also designated as a Qualified Infectious Disease Product.